- EZH2 (enhancer of zeste homolog 2) is a major epigenetic regulator and the catalytic methyltransferase subunit of Polycomb Repressive Complex 2 (PRC2). As a core component of the Polycomb system, EZH2 helps regulate gene expression by modifying chromatin and establishing repressive histone methylation marks. Its best-characterized activity is the methylation of lysine 27 on histone H3 (H3K27), particularly the formation of H3K27me3, a chromatin modification strongly associated with Polycomb-mediated gene repression. Through this activity, EZH2 contributes to the regulation of developmental genes, cell identity, stem-cell states, differentiation, and epigenetic memory.
- EZH2 belongs to the SET-domain family of protein lysine methyltransferases. Its catalytic SET domain is responsible for transferring methyl groups from the methyl donor S-adenosyl-L-methionine (SAM) to histone substrates. EZH2 does not function efficiently as an isolated protein, however. Its enzymatic activity is strongly dependent on its association with other PRC2 components, particularly SUZ12 and EED. RBBP4 and RBBP7 are also associated with canonical PRC2 complexes and contribute to complex stability and chromatin interactions. The coordinated action of these proteins allows PRC2 to recognize, modify, and regulate chromatin in a context-dependent manner.
- The major enzymatic function of EZH2 within PRC2 is the methylation of histone H3 at lysine 27. Histone H3 can carry one, two, or three methyl groups at this residue, producing H3K27me1, H3K27me2, and H3K27me3. EZH2-containing PRC2 can catalyze these methylation states, with H3K27me3 being particularly important for Polycomb-mediated transcriptional repression. H3K27me3 is frequently enriched at regulatory regions associated with genes that need to remain transcriptionally repressed during particular developmental or cellular states.
- The production and maintenance of H3K27me3 involve more than EZH2’s catalytic activity alone. EED, a component of PRC2, can recognize existing H3K27me3 and promote further PRC2 activity on nearby nucleosomes. This feedback mechanism provides one way in which Polycomb-associated chromatin states can be maintained and propagated. Such mechanisms contribute to epigenetic memory, allowing cells to preserve patterns of gene repression as they divide and differentiate.
- EZH2 functions within several forms of PRC2. Two major PRC2 assemblies are commonly described as PRC2.1 and PRC2.2, which differ in their associated accessory proteins and mechanisms of chromatin recruitment. PRC2.1 can contain proteins such as Polycomb-like proteins and EPOP or PALI-associated components, whereas PRC2.2 is characterized by accessory factors including JARID2 and AEBP2. These different PRC2 configurations allow EZH2-containing complexes to interact with chromatin through distinct mechanisms and contribute to the context-dependent distribution of H3K27 methylation.
- EZH2 is closely connected to the broader Polycomb system because PRC2-mediated H3K27me3 can cooperate with PRC1-mediated repression. Canonical PRC1 complexes can recognize H3K27me3 through chromodomain-containing CBX proteins, linking PRC2 activity to PRC1 recruitment. At the same time, non-canonical PRC1 complexes can contribute to Polycomb chromatin independently of pre-existing H3K27me3. The relationship between PRC1 and PRC2 is therefore more complex than a simple linear pathway, with the two systems interacting through multiple recruitment and chromatin-regulatory mechanisms.
- EZH2 is particularly important during embryonic development because many developmental genes must be activated or repressed at precisely controlled stages. By contributing to H3K27 methylation, EZH2-containing PRC2 complexes help maintain appropriate patterns of developmental gene expression. Genes involved in differentiation and cell-fate decisions can remain repressed until the appropriate developmental signals are received. Changes in Polycomb-mediated repression can therefore influence the transition between different cellular states.
- EZH2 also plays important roles in stem-cell biology. In embryonic stem cells and other stem or progenitor populations, Polycomb complexes help maintain a balance between self-renewal and differentiation. EZH2-mediated chromatin regulation can repress genes that promote differentiation while allowing stem cells to retain the capacity to respond to developmental signals. In some contexts, developmental genes can exist in chromatin states that combine repressive and activating features, often described as bivalent chromatin. PRC2 and H3K27me3 are important components of these regulatory states.
- Although EZH2 is strongly associated with gene repression, its biological effects are context-dependent. The presence of EZH2 or H3K27me3 at a genomic region does not by itself provide a complete explanation of gene expression. Chromatin accessibility, transcription factors, other histone modifications, DNA methylation, PRC1 activity, enhancer activity, and the local cellular environment can all influence whether a gene is expressed or repressed. EZH2 should therefore be viewed as part of a broader chromatin-regulatory network rather than as an independent switch that simply turns genes off.
- EZH2 activity is also regulated by mechanisms beyond its incorporation into PRC2. Post-translational modifications, protein-protein interactions, cellular signaling pathways, and changes in the abundance of PRC2 components can influence its activity and genomic distribution. These regulatory mechanisms allow EZH2-mediated chromatin modification to respond to developmental and environmental signals. The balance between EZH2 activity and the activity of histone demethylases such as KDM6A and KDM6B contributes to the dynamic regulation of H3K27 methylation.
- EZH2 has attracted considerable attention in cancer biology because abnormal Polycomb activity is associated with many cancers. EZH2 overexpression, altered regulation, or activating mutations have been reported in several cancer types, and increased EZH2 activity can contribute to inappropriate repression of genes involved in differentiation, cell-cycle control, and other cellular processes. In some cancers, EZH2-dependent chromatin regulation can support tumor-cell proliferation or survival. However, the biological consequences of EZH2 alterations vary among cancer types and cellular contexts.
- The connection between EZH2 and cancer has also led to the development of EZH2-targeting drugs. Pharmacological inhibitors can interfere with the methyltransferase activity of EZH2 and reduce PRC2-dependent H3K27 methylation. These compounds have been investigated and used in specific clinical settings, particularly for cancers in which EZH2 activity is an important therapeutic target. EZH2 inhibition is also an important research tool for studying the functional consequences of H3K27 methylation and Polycomb-mediated repression.
- EZH2 is closely related to EZH1, another catalytic subunit that can function in PRC2. EZH1 and EZH2 share important structural and biochemical features but are not completely interchangeable. Their relative contributions can vary according to cell type, developmental state, and tissue context. This distinction is important because loss or inhibition of EZH2 does not necessarily eliminate all PRC2-dependent H3K27 methylation.
- The activity of EZH2 can be studied using several experimental approaches. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) can be used to map EZH2 or H3K27me3 across the genome. Chromatin profiling methods can reveal the genomic regions associated with PRC2 and its histone modifications, while RNA sequencing can be used to investigate changes in gene expression following EZH2 perturbation. Biochemical assays, genetic knockout or knockdown experiments, and pharmacological inhibition provide complementary approaches for determining how EZH2 influences chromatin and cellular behavior.
- EZH2 is also an important example of how epigenetic regulation integrates enzymatic activity with chromatin organization. Its methyltransferase activity modifies histones, but the resulting chromatin state can influence the recruitment and behavior of other chromatin-associated proteins. PRC2 therefore participates in a network involving histone modifications, nucleosome organization, transcription factors, DNA methylation, chromatin remodeling, and three-dimensional genome organization.
- An important distinction is that EZH2 is not synonymous with H3K27me3. EZH2 is a protein and catalytic component of PRC2, whereas H3K27me3 is a histone modification produced by PRC2-mediated methylation. Similarly, PRC2 is a multiprotein complex rather than a single enzyme. Understanding these distinctions is important when interpreting studies of Polycomb-mediated gene regulation and when connecting EZH2 biology with other components of the epigenetic machinery.
- EZH2 therefore occupies a central position within the Polycomb regulatory system. Through its association with PRC2, it contributes to the establishment and regulation of H3K27 methylation and helps control genes involved in development, differentiation, stem-cell biology, cellular identity, and epigenetic memory. Its dysregulation can contribute to disease, particularly cancer, making EZH2 both an important subject of fundamental epigenetics research and a significant therapeutic target. Understanding EZH2 also provides a foundation for studying PRC2 structure, H3K27 methylation, Polycomb recruitment, histone demethylases, and the broader mechanisms through which chromatin states regulate gene expression.
